Edition:
United States

Alexion Pharmaceuticals Inc (ALXN.OQ)

ALXN.OQ on NASDAQ Stock Exchange Global Select Market

108.05USD
21 Nov 2017
Change (% chg)

-- (--)
Prev Close
$108.05
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
606,763
52-wk High
$149.17
52-wk Low
$96.18

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 859.00 0.347
Jun '17 912.00 0.733
Mar '17 870.00 0.752
FY 2016 Dec '16 830.74 0.405
Sep '16 799.11 0.417
Jun '16 753.12 0.509
Mar '16 701.04 0.406
FY 2015 Dec '15 700.87 0.292
Sep '15 666.64 -0.812
Jun '15 636.21 0.832
Mar '15 600.33 0.452
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-17 18 879.28 900.89 848.00 949.82
Quarter Ending Mar-18 8 934.44 991.86 877.00 985.70
Year Ending Dec-17 21 3,518.97 3,540.89 3,488.00 3,565.52
Year Ending Dec-18 21 4,089.73 4,304.88 3,907.00 4,272.42
Earnings (per share)
Quarter Ending Dec-17 19 1.27 1.53 1.11 1.51
Quarter Ending Mar-18 9 1.51 1.79 1.27 1.75
Year Ending Dec-17 21 5.64 5.90 5.27 5.63
Year Ending Dec-18 21 7.08 8.64 6.35 7.40
LT Growth Rate (%) 7 19.64 24.70 14.00 18.18
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) 48.30 31.41 34.68
P/E High - Last 5 Yrs. 285.27 40.46 45.18
P/E Low - Last 5 Yrs. 56.79 23.56 24.20
Beta 1.25 0.91 0.89
Price to Sales (TTM) 6.95 3.84 5.28
Price to Book (MRQ) 2.69 4.77 5.58
Price to Tangible Book (MRQ) -- 5.58 7.10
Price to Cash Flow (TTM) 26.32 22.74 23.65
% Owned Institutions 97.05 0.74 1.28

Dividends

  Company industry sector
Dividend Yield -- 1.56 1.49
Dividend Yield - 5 Year Avg -- 2.15 2.03
Dividend 5 Year Growth Rate -- 4.36 5.31
Payout Ratio(TTM) 0.00 46.57 45.48

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 7.50 6.31 6.93
Sales (TTM) vs TTM 1 Yr. Ago 17.52 4.67 5.15
Sales - 5 Yr. Growth Rate 31.53 10.11 10.34
EPS (MRQ) vs Qtr. 1 Yr. Ago -16.92 4.32 4.86
EPS (TTM) vs TTM 1 Yr. Ago 35.85 -- --
EPS - 5 Yr. Growth Rate 13.97 10.02 11.02
Capital Spending - 5 Yr. Growth Rate 72.22 15.13 15.11

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 2.51 2.49 2.54
Current Ratio (MRQ) 2.97 3.51 3.55
LT Debt to Equity (MRQ) 34.62 9.88 12.26
Total Debt to Equity (MRQ) 36.48 15.94 18.26
Interest Coverage (TTM) 6.71 48.27 43.11

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 89.13 55.01 54.73
Gross Margin - 5 Yr. Avg. 90.95 52.05 52.22
EBITD Margin (TTM) 36.66 -- --
EBITD - 5 Yr. Avg 37.04 18.35 15.69
Operating Margin (TTM) 18.58 14.65 8.10
Operating Margin - 5 Yr. Avg. 28.33 14.45 11.33
Pre-Tax Margin (TTM) 16.20 15.11 8.95
Pre-Tax Margin - 5 Yr. Avg. 27.06 14.78 11.74
Net Profit Margin (TTM) 14.56 11.29 5.18
Net Profit Margin - 5 Yr. Avg. 16.10 11.10 8.02
Effective Tax Rate (TTM) 10.12 24.31 24.21
Effective Tax Rate - 5 Yr. Avg. 40.49 23.44 24.06

Efficiency

  Company industry sector
Revenue/Employee (TTM) 1,112,381 960,288,394 864,771,004
Net Income/Employee (TTM) 161,947 112,049,537 100,828,627
Receivable Turnover (TTM) 5.02 5.83 6.12
Inventory Turnover (TTM) 0.94 2.72 3.51
Asset Turnover (TTM) 0.26 1.00 0.97

Management Effectiveness

  Company industry sector
Return on Assets (TTM) 3.75 11.92 11.38
Return on Assets - 5 Yr. Avg. 5.59 13.00 12.41
Return on Investment (TTM) 4.05 15.15 14.55
Return on Investment - 5 Yr. Avg. 6.15 17.00 16.25
Return on Equity (TTM) 5.79 16.57 16.07
Return on Equity - 5 Yr. Avg. 8.20 17.95 17.40
  1 Year 3 Year 5 Year
Sales % 18.43 25.74 31.53
EPS (TTM) % 162.87 11.55 13.97
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Alexion Pharmaceuticals Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -19.76 -20.29 7 17
13 Week -18.69 -23.53 13 13
26 Week -6.00 -12.85 42 26
52 Week -9.48 -23.51 32 23
YTD -11.33 -23.12 29 22
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 97.04%
# of Holders: 861
Total Shares Held: 216,799,174
3 Mo. Net Change: -147,886
# New Positions: 93
# Closed Positions: 53
# Increased Positions: 370
# Reduced Positions: 323
# Net Buyers: 47
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.